ROLE OF MAC IN INHALATIONAL INDUCTION OF THE PEDIATRIC PATIENT

A Comprehensive Review for the PG Resident | MD Final Anesthesia Examination

PART I: MAC - THE FOUNDATIONAL CONCEPT

What is MAC?

• It is the EC50 (median effective concentration) for immobility - analogous to the ED50 for intravenous drugs
• It mirrors brain partial pressure at steady state, because the alveolar partial pressure equilibrates rapidly with the well-perfused brain
• It is expressed in vol% (e.g., sevoflurane MAC = 2.0% in adults 30-55 years)
• It allows comparison of potency across agents (lower MAC = more potent)
• It is a population statistic, not an individual guarantee - at exactly 1.0 MAC, 50% of patients still move

MAC Values of Common Agents (Adults, 30-55 years)

The MAC Family - Critical for Exams

PART II: AGE-RELATED MAC CHANGES - THE PEDIATRIC PARADIGM

The Age-MAC Relationship

MAC is LOWEST in preterm neonates → rises ~30% from birth → PEAKS between 1-6 months of age → progressively DECREASES throughout childhood, adolescence, and adult life.

Sevoflurane MAC by Pediatric Age (Most Exam-Relevant Agent)

Why Does MAC Peak in Infancy? (The "Why" for Viva)

1. Higher brain metabolic rate in infants - greater CNS activity demands higher anesthetic concentrations to suppress neuronal responses
2. Neurotransmitter composition - different balance of excitatory (glutamate, NMDA) and inhibitory (GABA) receptor populations in the developing brain
3. Receptor composition - GABA-A receptor subunit composition changes with age; neonatal receptors are less sensitive to volatile anesthetics
4. Progesterone effect - falls from fetal levels after birth (progesterone reduces MAC); may explain the relative drop from fetal to term neonate
5. Preterm lower MAC - possibly related to retained progesterone from placental exposure and greater CNS immaturity

PART III: WHY MAC MATTERS IN PEDIATRIC INHALATIONAL INDUCTION

Pharmacokinetic Basis: Why Kids Breathe Down Faster

• Infants: MV/FRC ratio ≈ 5:1 (adults ≈ 1.5:1)
• The alveolar partial pressure (FA) rises toward the inspired partial pressure (FI) much faster - the FA/FI ratio climbs steeply
• Result: Faster induction, but also faster risk of overdose

• While this coefficient is fixed per agent, the rapid FA/FI rise means even relatively soluble agents (halothane, isoflurane) equilibrate fast in children
• Sevoflurane (blood:gas = 0.69) rises particularly fast - this is why it is the agent of choice for pediatric inhalational induction

• More drug delivered per unit time to brain
• But also more rapid redistribution, which partly offsets this

• More drug partitions into neonatal tissues
• Prolongs emergence somewhat

PART IV: FACTORS MODIFYING MAC IN PEDIATRIC PATIENTS

Factors That INCREASE MAC (higher anesthetic dose needed)

Factors That DECREASE MAC (lower anesthetic dose needed)

What Does NOT Affect MAC? (Classic Viva Trap)

• Duration of anesthesia
• Gender (except the red hair exception)
• Type of surgical stimulation
• Thyroid function (alone)
• Hypo/hypercarbia (within normal limits)
• Hyperkalemia
• Magnesium levels
• Metabolic alkalosis

PART V: CLINICAL APPLICATION IN PEDIATRIC INHALATIONAL INDUCTION

Why Choose Inhalational Induction in Children?

1. Fear of needles (needle phobia) - majority of children refuse IV placement
2. Difficult IV access
3. Uncooperative child - avoids physical restraint
4. Difficult airway anticipated - allows spontaneous ventilation to be maintained
5. Full stomach (relative) - controlled, awake induction sometimes modified
6. Parental anxiety - smoother family experience

Agent of Choice: SEVOFLURANE

• Single-breath technique: Pre-fill circuit with 8% sevoflurane + 50-70% N2O in oxygen → child takes single vital capacity breath → LOC in 30-60 seconds
• Incremental technique: Start at 2%, increase by 0.5-1% every 3-5 breaths
• N2O 50-70% added for its speed advantage (second gas effect) and analgesic/anxiolytic properties

BIS (Bispectral Index) and MAC in Children

• Children show higher BIS values for a given fraction of MAC compared to adults
• In neonates and infants, the MAC-EEG relationship is substantially different and poorly understood
• Therefore, relying on BIS alone to judge depth in young children is unreliable - clinical signs (heart rate, blood pressure, movement, lacrimation) remain important

MAC-awake in Pediatric Context

• Same ratio applies: ~0.3-0.4 MAC for MAC-awake
• In sevoflurane terms: ~0.6-0.8% end-tidal for consciousness to return
• There is hysteresis - it takes 0.4-0.5 MAC to lose consciousness but only 0.15 MAC to regain it (wash-out kinetics differ from wash-in)
• Emergence delirium is more common with sevoflurane vs halothane in children - may be related to rapid emergence (fast drop from high-MAC induction to sub-MAC-awake)

PART VI: SPECIAL CONSIDERATIONS BY AGE GROUP

Preterm Neonate

• Lowest MAC of all groups
• Highest overdose risk due to rapid equilibration
• Cardiovascular compromise at lower MAC multiples
• Avoid or minimize halothane completely
• Sevoflurane is safer but still requires vigilance
• Consider TIVA or combined technique

Term Neonate (0-28 days)

• MAC sevoflurane: 3.3% - highest among all age groups for this agent
• Myocardial depression greater at equivalent MAC multiples than older children
• Dose-dependent ventilatory depression - apnea risk high
• Cardiovascular depression dose-dependent and more pronounced than older children

Infants (1-12 months)

• MAC peaks at 1-6 months (3.2% for sevoflurane)
• Faster equilibration than older children
• Laryngospasm risk high during airway instrumentation - respect depth of anesthesia
• Higher O2 consumption → hypoxia develops faster during apnea

Children (1-12 years)

• MAC decreasing toward adult values after 6 months
• Emergence delirium peak incidence 2-5 years old
• BIS unreliable; use clinical endpoints
• Overpressure technique safer now (lower MAC requirement vs infants)

PART VII: ADDITIVITY AND THE CLINICAL MATH

MAC Additivity

• 0.5 MAC sevoflurane + 0.5 MAC N2O = 1.0 MAC for immobility
• Addition of N2O to sevoflurane reduces the sevoflurane requirement - useful to speed induction and reduce emergence delirium
• Caveat: MAC additivity for immobility does NOT equal additivity for cardiovascular depression
  • Example: 0.6 MAC N2O + 0.6 MAC isoflurane = less hypotension than 1.2 MAC isoflurane alone (because isoflurane is a more potent vasodilator at equivalent MAC)

Opioid + Volatile Combination

• IV fentanyl or morphine given during maintenance significantly reduces volatile requirement (decreases MAC-BAR)
• Allows lower end-tidal concentrations → less cardiovascular depression → faster emergence
• This is the basis for balanced anesthesia

Dexmedetomidine MAC-Sparing Effect

• Dexmedetomidine (alpha-2 agonist) is a potent MAC-reducer - reduces sevoflurane requirement by 30-50%
• Used for premedication in children (intranasal 1-2 mcg/kg) - reduces emergence delirium AND reduces MAC requirement
• Recent RCT (PMID 40661827) confirmed dexmedetomidine's significant reduction in MAC for sympathetic responses

PART VIII: VIVA QUESTIONS WITH MODEL ANSWERS

MAC is the alveolar concentration of an inhaled anesthetic at 1 atmosphere that prevents movement in 50% of subjects in response to a standardized surgical stimulus. Limitations: (1) It is an EC50, so 50% of patients will still move at 1.0 MAC; (2) It is a population median, not applicable to individuals; (3) It is not a guarantee of amnesia, only immobility; (4) It has limited usefulness during rapidly changing concentrations (induction, emergence); (5) BIS/EEG correlation is unreliable in children.

MAC is lowest in preterm neonates, rises approximately 30% from birth, and peaks between 1-6 months of age. It then progressively decreases throughout childhood and adult life. For sevoflurane: preterm ~2.5-3.0%, term neonate 3.3%, infant 1-6 months 3.2%, children >6 months 2.5%, adults 2.0%. The decrease from infancy onward is approximately 6% per decade. The reason for the infantile peak is not fully elucidated but is thought to involve developmental differences in GABA-A receptor subunit composition, CNS metabolic rate, and neurotransmitter balance.

The primary reason is a higher minute ventilation-to-FRC ratio (approximately 5:1 in infants vs 1.5:1 in adults), which causes the FA/FI ratio to rise steeply and rapidly. Additionally, cardiac output is high relative to body weight, delivering more drug to the brain per unit time. Lower tissue solubility of modern agents (sevoflurane) further accelerates equilibration. The net result is that neonates reach steady-state brain partial pressure much faster than adults, but this also means they are at much higher risk of accidental overdose.

Sevoflurane is preferred because: (1) Non-pungent - allows smooth mask induction without airway irritation or breath-holding; (2) Low blood:gas coefficient (0.69) - faster induction and emergence; (3) Does NOT sensitize the myocardium to catecholamines - halothane causes ventricular arrhythmias with exogenous or endogenous adrenaline; (4) Less hepatotoxicity risk (halothane hepatitis is rare but life-threatening); (5) Less myocardial depression at clinically used concentrations; (6) Vaporizer maximum output limited to 2.42 MAC multiples - inherent safety margin vs halothane's 5.75 MAC multiples.

MAC-BAR (Minimum Alveolar Concentration - Blunting Adrenergic Response) is the alveolar concentration that blunts the sympathetic (adrenergic) response to surgical skin incision in 50% of patients. It is approximately 1.5 times the standard MAC. Clinically, reaching MAC-BAR ensures hemodynamic stability during stimulating portions of surgery. In children, the ratio of MAC to MAC-BAR is similar to adults. Achieving MAC-BAR requires a higher volatile concentration, which increases the risk of cardiovascular depression - in practice, opioids or alpha-2 agonists are added to attenuate adrenergic responses at lower volatile concentrations, thus sparing MAC-BAR.

(1) Alpha-2 agonists (dexmedetomidine): Activate alpha-2 receptors in locus coeruleus → reduced noradrenergic outflow → CNS sedation → potent MAC reduction (30-50%); (2) Opioids: Act on mu-opioid receptors in spinal cord and brain → decrease pain transmission and CNS arousal → dose-dependent MAC reduction; (3) Hypothermia: Reduced neuronal metabolic rate → less neural activity to suppress → approximately 5% MAC reduction per 1°C below 37°C; (4) Pregnancy: Progesterone (also effective in neonates exposed to maternal progesterone) reduces MAC by up to 30% via GABA-A receptor modulation.

The child's MAC for sevoflurane at 6 months is approximately 3.2%. At an end-tidal of 2.0%, you are delivering only 0.625 MAC - far below the 1.0 MAC required for a 50% probability of immobility, and certainly below the 1.3 MAC needed for 95% probability. The child will move in virtually all cases. You need to increase the end-tidal to at least 3.2% (1.0 MAC) or ideally 4.2% (1.3 MAC) if no other agents are used. Alternatively, add N2O to contribute 0.5 MAC, allowing sevoflurane to be maintained at 1.6% (0.5 MAC) for a total of 1.0 MAC. Also consider supplemental analgesia with fentanyl or a regional block to achieve MAC-BAR equivalence at lower volatile concentrations.

The relationship between MAC and the electroencephalogram is substantially different in infants and neonates compared to adults. Children show higher BIS values at equivalent MAC fractions, and in neonates, the MAC-EEG relationship is unknown. This is thought to be due to developmental differences in cortical maturation, myelination, and synaptic connectivity. BIS was validated in adult populations. Clinical signs remain the cornerstone: heart rate (tachycardia = light), blood pressure (hypertension = light), movement, lacrimation, diaphoresis, and pupillary dilation.

The second gas effect occurs when a large volume of a first gas (typically N2O) is rapidly absorbed from the alveoli, concentrating the remaining alveolar gases (including the volatile agent - the second gas) and increasing alveolar ventilation as fresh gas rushes in to fill the void. The net effect is a faster rise in the alveolar partial pressure of the volatile agent. In pediatric inhalational induction, adding 50-70% N2O alongside sevoflurane exploits this effect to speed induction, reduce the concentration of sevoflurane needed (MAC additivity), and provide analgesic and anxiolytic properties of N2O. The Fink effect (diffusion hypoxia) at emergence when N2O is discontinued is countered by administering 100% O2 for the final 5-10 minutes.

In a difficult airway infant: (1) Must maintain spontaneous ventilation throughout induction - avoid overshooting to MAC levels that cause apnea; (2) Target 1.0-1.2 MAC for laryngoscopy (MAC intubation ~1.3 MAC) - below this, the patient is lightly anesthetized and will have laryngospasm; (3) In a 3-month-old, this means targeting 3.2-4.2% sevoflurane end-tidal - significantly higher than adult expectations; (4) The infant's rapid equilibration means you will reach these concentrations faster - do not be complacent; (5) Maintain oxygen saturation with continuous monitoring - high O2 consumption in infants means desaturation during apnea or laryngospasm is rapid and severe; (6) Halothane is absolutely avoided (no sensitization risk is irrelevant - the cardiovascular depression risk is too high at the concentrations needed).

SUMMARY TABLE: MAC IN PEDIATRICS - EXAM RAPID REVIEW

ANESTHETIC IMPLICATIONS FOR MD FINAL EXAM

1. Always recalculate MAC targets for the specific age of your pediatric patient - using adult MAC values is a serious error.
2. Neonates need the highest sevoflurane concentrations despite being the most vulnerable to cardiovascular depression - monitor closely and do not use higher MAC multiples than necessary.
3. Overpressure technique (high inspired concentration to speed induction) is more dangerous in neonates than in older children - use with caution and avoid halothane entirely.
4. MAC additivity allows N2O to significantly reduce volatile requirements - use routinely unless contraindicated (pneumothorax, bowel obstruction, middle ear surgery).
5. Premedication with dexmedetomidine or midazolam reduces MAC requirement AND reduces emergence delirium - this is evidence-based and cost-effective pediatric anesthesia practice.
6. Emergence delirium with sevoflurane is partly a consequence of rapid fall from high MAC-induction concentrations to sub-MAC-awake - strategies include propofol 1 mg/kg at end of surgery, dexmedetomidine, regional blocks (reduce required MAC during surgery), and slow, controlled emergence.
7. BIS monitoring in children under 2 years is unreliable - do not use it as your sole depth monitor.
8. EEG-guided titration of sevoflurane in older children shows promise for reducing emergence delirium per a 2025 RCT in JAMA Pediatrics (PMID 40257811).
9. Laryngospasm during light anesthesia in children is a MAC-related phenomenon - always ensure adequate depth (>1.0 MAC) before airway instrumentation.
10. Cardiac depression is age-dependent - the myocardial depressant effect of all volatile agents is greater in neonates at equivalent MAC multiples than in older children.